Derek N. Middlemiss

Derek N. Middlemiss publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Derek N. Middlemiss sits on this spectrum.

Derek N. Middlemiss D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Derek N. Middlemiss sits on this spectrum.

Best Publications

• Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor

  N. G. Bowery;D. R. Hill;A. L. Hudson;A. Doble

  1569
  Citations

• Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine

  P.B. Bradley;G. Engel;W. Feniuk;J.R. Fozard

  1408
  Citations

• 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.

  Derek N. Middlemiss;John R. Fozard

  1290
  Citations

• SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist.

  G.A. Kennett;M.D. Wood;F. Bright;B. Trail

  786
  Citations

• Species differences in the pharmacology of terminal 5-HT autoreceptors in mammalian brain

  Daniel Hoyer;Derek N. Middlemiss

  377
  Citations

• A functional correlate for the dihydropyridine binding site in rat brain.

  D. N. Middlemiss;M. Spedding

  360
  Citations

• Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A.

  Reavill C;Taylor Sg;Wood;Ashmeade T

  354
  Citations

• Characterization of SB‐269970‐A, a selective 5‐HT7 receptor antagonist

  Jim J Hagan;Gary W Price;Phillip Jeffrey;Nigel J Deeks

  348
  Citations

• Dopamine D3 Receptor Antagonism Inhibits Cocaine-Seeking and Cocaine-Enhanced Brain Reward in Rats

  Stanislav R. Vorel;Charles R. Ashby;Mousumi Paul;Xinhe Liu

  343
  Citations

• Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol

  Derek N. Middlemiss

  295
  Citations

• Cardiovascular response to 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) in the rat: site of action and pharmacological analysis.

  John R. Fozard;Anis K. Mir;Derek N. Middlemiss

  295
  Citations

• Direct evidence for an interaction of β-adrenergic blockers with the 5-HT receptor

  Unknown

  274
  Citations

• Characterization of recombinant human orexin receptor pharmacology in a Chinese hamster ovary cell‐line using FLIPR

  D Smart;J C Jerman;S J Brough;S L Rushton

  271
  Citations

• 5-Chloro-N-(4-methoxy-3-piperazin-1-yl- phenyl)-3-methyl-2-benzothiophenesulfon- amide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist.

  Steven M. Bromidge;Anthony M. Brown;Stephen E. Clarke;Kathy Dodgson

  262
  Citations

• Graphics computer-aided receptor mapping as a predictive tool for drug design: development of potent, selective, and stereospecific ligands for the 5-HT1A receptor

  Marcel F. Hibert;Maurice W. Gittos;Derek N. Middlemiss;Anis K. Mir

  243
  Citations

• SB-216641 and BRL-15572--compounds to pharmacologically discriminate h5-HT1B and h5-HT1D receptors.

  G. W. Price;M. J. Burton;L. J. Collin;M. Duckworth

  235
  Citations

• Molecular cloning of a serotonin receptor from human brain (5HT1E): a fifth 5HT1-like subtype.

  G McAllister;A Charlesworth;C Snodin;M S Beer

  230
  Citations

• The expression of GABAB1 and GABAB2 receptor subunits in the cNS differs from that in peripheral tissues

  A.R. Calver;A.D. Medhurst;M.J. Robbins;K.J. Charles

  219
  Citations

• Characterization of SB-271046 : A potent, selective and orally active 5-HT6 receptor antagonist

  Carol Routledge;Steven M Bromidge;Stephen F Moss;Gary W Price

  212
  Citations

• Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat.

  Mark D. Tricklebank;Christian Forler;Derek N. Middlemiss;John R. Fozard

  202
  Citations